"/> Novus Biologicals™ Peptide bloquant d’anticorps xCT | B-LABO France

Novus Biologicals™ Peptide bloquant d’anticorps xCT

Réf. : BL-RE-054118Réf. fabricant : 18286960 0.05 mg
128,51 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
23657
Espèces
Human
Contenu et stockage
Store at -80 C. Avoid freeze-thaw cycles.
Formule
Peptide dissolved in dH2O. Contains no BSA.
À utiliser avec (application)
This Peptide is Useful as a Blocking Peptide for NB300-317. ICC/IF Was Reported in Scientific Literature (PMID: 21639880). For Further Blocking Peptide Related Protocol, Click Here .
Marque
Novus Biologicals

A peptide to SLC7A11. The xCT Blocking Peptide has been validated for the following applications: Antibody Competition.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-054118
Réf. fabricant18286960
Gene ID (Entrez)23657
EspècesHuman
Contenu et stockageStore at -80 C. Avoid freeze-thaw cycles.
FormulePeptide dissolved in dH2O. Contains no BSA.
À utiliser avec (application)This Peptide is Useful as a Blocking Peptide for NB300-317. ICC/IF Was Reported in Scientific Literature (PMID: 21639880). For Further Blocking Peptide Related Protocol, Click Here .
Alias de gèneAmino acid transport system xc-, Calcium channel blocker resistance protein CCBR1, cystine/glutamate transporter, Member 11 (Slc7a11), Solute carrier family 7 member 11, solute carrier family 7, (cationic amino acid transporter, y+ system) member 11, xCTCCBR1
Symbole de gène(s)SLC7A11
Type de produitxCT
Quantité0.05 mg
État réglementaireRUO - research use only
Catégorie de rechercheAmino Acids Drugs and other small molecules, Cancer, Cell Biology, Lipid and Metabolism, Neuronal Cell Markers, Neuroscience, Neurotransmission, Signal Transduction
Une question, une configuration particulière ?
Contactez-nous pour un devis.